Oak Associates LTD Eagle Pharmaceuticals, Inc. Transaction History

Oak Associates LTD

  • $1.48 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$37.02 - $51.28 $745,027 - $1.03 Million
-20,125 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$34.37 - $60.07 $2,062 - $3,604
-60 Reduced 0.3%
20,125 $926,000
Q2 2019

Aug 09, 2019
BUY
$46.61 - $58.45 $557,688 - $699,354
11,965 Added 145.56%
20,185 $1.12 Million
Q1 2018

May 14, 2018
BUY
$52.16 - $66.86 $428,755 - $549,589
8,220 New
8,220 $433,000

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.16M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Oak Associates LTD Portfolio

Follow Oak Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email